Background
==========

The World Health Organization (WHO) estimates that up to 80% of the population in Africa makes use of traditional medicine as well as about 65% of the world\'s population \[[@B1]\]. Plants used in traditional medicine, also called phytomedicine are plant-derived medicines that contain chemicals, more usually, mixtures of chemical compounds that act individually or in combination on the human body to prevent disorders and to restore or maintain health \[[@B2]\]. With up to 19,581 indigenous species, South Africa has the richest temperate flora in the world. A minimum of 11,700 species are endemic to South Africa \[[@B3]\] and nearly 3,000 species are used as medicines with approximately 350 species forming the most commonly traded and used medicinal plants \[[@B4]\]. Hence, there is good reason to screen these traditionally used plants for new drug discovery. The ethnobotanical approach has a number of advantages when searching for new drug candidates. The plants have been 'pre-screened' through generations of trial and error processes occurring over hundreds or thousands of years \[[@B5]\]. This will result in a higher probability of producing useful therapies from a group of medicinal plants, and one can rationalize that any isolated active compounds from plants are likely to be safer than active compounds from plants with no history of human use \[[@B5],[@B6]\]. The present work was therefore designed to investigate the antimicrobial activity of twelve selected South African medicinal plants, *Acacia karroo* Hayne (Mimosoideae), *Acokanthera oppositifolia* (Lam.) Codd (Apocynaceae), *Bulbine latifolia* (L.f.) Spreng var. *Latifolia* (Asphodelaceae), *Curtisia dentata* (Burm.f.) C.A.Sm. (Cornaceae), *Erythrophleum lasianthum* Corbishley (Caesalpinioideae), *Knowltonia vesicatoria* Sims (Ranunculaceae), *Ptaeroxylon obliquum* (Thunb.) Radlk. (Ptaeroxylaceae), *Salvia africana-lutea* L. (Lamiaceae), *Sansevieria hyacinthoides* Hort. ex Steud. (Dracaenaceae).

Methods
=======

Plant materials and extraction
------------------------------

All plants were collected on the Campus area of the University of Pretoria in August 2007. The plant parts were mainly aerial parts such as leaves, stems and flowers, except for *S. hyacinthoides* where the rhizome was dug up and collected, based on the traditional uses (Table [1](#T1){ref-type="table"}). The plants were then identified at the HGWJ Schweicherdt Herbarium, University of Pretoria and a voucher specimen was preserved there as well (Table [1](#T1){ref-type="table"}). The air dried and powdered sample from each plant (10 g) were macerated in methanol (300 ml) for 48 h at room temperature with occasional shaking. After 48 hours the extract was filtered through a Whatmann no. 1 filter paper. The extract was then concentrated under reduced pressure to give the crude extracts. They were then kept at 4 °C until further use.

###### 

Plants used in the present work

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **Botanical name**\                                                     **voucher specimen**               **Parts used, extraction yield**          **Traditional use**
  **(FAMILY)**                                                                                                                                         
  ----------------------------------------------------------------------- ---------------------------------- ----------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Acacia karroo* Hayne^A^ (Mimosoideae)                                  T. Nielsen PRU 096395              Leaves, 25.1% Stem + Bark, 13.6%          Mouth ulcers, oral thrush^E^, diarrhea, dysenteries, colic, colds^G^, other *Acacia* species: asthma, bronchitis, cough, phithisis, fever, leprosy, chest and respiratory ailments^H^.

  *Acokanthera oppositifolia* (Lam.) Codd^A^ (Apocynaceae)                T. Nielsen PRU 0963388             Leaves, 27.7% Stem, 12.6%                 Hunting poison^F^, snakebites^D^, abnormal menstruation, snuff for headaches, septicaemia, toothache^E^.

  *Bulbine latifolia* (L.f.) Spreng var. *latifolia*^A^ (Asphodelaceae)   T. Nielsen PRU 096391              Leaves, 0.5%                              Wounds, burns, skin conditions^E^, diarrhoea, dysenteries, abdominal ailments^G^, rheumatism^H^.

  *Curtisia dentata* (Burm.f.) C.A.Sm.^A^ (Cornaceae)                     T. Nielsen PRU 096385              Leaves, 33.7% Stem, 15.1%                 Stomach ailments, diarrhea, blood purifier, afrodisiac^E^, tanning, chewing sticks^G^.

  *Erythrophleum lasianthum* Corbishley^A^ (Caesalpinioideae)             No voucher specimen available \*   Leaves, 41.2% Stem, 31.2%                 Headaches^D^, fever^H^, *Erythrophleum* species: heart problem, dermatitis, wounds, rheumatism, syphilis, gonorrhea, leprosy, tuberculosis, bronchitis, angina, ordeal and hunting poison^F^.

  *Knowltonia vesicatoria* Sims^B^ (Ranunculaceae)                        T. Nielsen PRU 096390              Aerial parts, 31.4%                       Tooth pain^E^, rheumatism, lumbago, colds, influenza^G^, skin tumor^H^.

  *Ptaeroxylon obliquum* (Thunb.) Radlk.^A^ (Ptaeroxylaceae)              T. Nielsen PRU 096389              Leaves, 23.1%, Stem, 16.1%, Bark, 13.7%   Snuff for headaches^D^, rheumatism, arthritis^E^, heart disease, anthrax, sinusitis, lupus, warts^G^, sternutatory^H^.

  *Salvia africana-lutea* L.^A^ (Lamiaceae)                               T. Nielsen PRU 096396              Aerial parts, 29.2%                       Colds, flu, bronchitis, abdominal and uterine troubles^E^, cough, chest troubles^G^, other *Salvia* species: night sweat tuberculosis, respiratory and pulmonary ailments, ^G,H^ .

  *Sansevieria hyacinthoides* Hort. ex Steud.^B^ (Dracaenaceae)           T. Nielsen PRU 0963387             Leaves, 11.9% Rhizome, 12.7%              Earache, stomachache, toothache, hemorrhoids, ulcers, diarrhea, intestinal parasites^E^, Sansevieria species: chest diseases, cough remedy^F^.

  *Searsia burchellii* (Sond. ex Engl.) Moffett^C^ (Anarcardiaceae)       T. Nielsen PRU 096386              Leaves, 24.5% Stem, 9.4%                  Chest colds^G^, *Rhus (Searsia)* species: colds, cough, expectorant, febrifuge, pulmonary ailments, tuberculosis^H^.

  *Typha capensis* Rohrb.^B^ (Typhaceae)                                  T. Nielsen PRU 096394              Leaves, 17.0%                             Fertility, potency, circulation, delivery, venereal diseases, dysentery, diarrhea, enteritis, blood purifier^E^, gonorrhea, pulmonary ailments^H^.

  *Zantedeschia aethiopica* (L.) Spreng.^A^ (Araceae)                     T. Nielsen PRU 096392              Leaves + Stem, 15.2%                      Wounds, sores, boils^E,G^, insect bites, gout, rheumatism^G,H^.
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

A: A checklist of South African plants \[[@B3]\]; B: The International Plants Names Index \[[@B7]\] C: Moffett \[[@B8]\]; D: Trees of Southern Africa \[[@B9]\]; E: People's Plants \[[@B2]\], F: African Ethnobotany \[[@B10]\]; G: The Medicinal and Poisonous Plants of Southern and Eastern Africa \[[@B11]\]; H: CRC Ethnobotany Desk Reference \[[@B12]\].

\* No reproductive parts (flowers, fruits) could be collected from this plant; consequently no herbarium specimen is available.

Chemicals for antimicrobial assay
---------------------------------

Nystatin (Maneesh Pharmaceutic PVT) for fungi, ciprofloxacin and isoniazid (INH) (Sigma-Aldrich, Johannesburg, South Africa) for *Mycobacterium smegmatis and M. tuberculosis* respectively and gentamicin (Jinling Pharmaceutic Group corp.) for other bacteria were used as reference antibiotics (RA).

Microorganisms and culture media
--------------------------------

The tested organisms included *Mycobacterium smegmatis* ATCC 700084 \[obtained from South African Medical Research Council, Pretoria and authenticated by Professor Fanus Venter, Department of Microbiology and Plants Pathology, University of Pretoria\], drug-susceptible strain of *Mycobacterium tuberculosis* H37Rv ATCC 27294 (America Type Culture Collection, Rockville, MD, USA), Methicillin-resistant *Staphylococcus aureus* (MRSA, LMP805) (Gram-positive bacterium), four Gram-negative bacteria namely β-lactamase positive (βL^+^) *Escherichia coli* (βL^+^EC, LMP701), Ampicillin-resistant *Klebsiella pneumoniae* (ARKP, LMP803), Carbenicillin-resistant *Pseudomonas aeruginosa* (CRPA, LMP804), Chloramphenicol-resistant *Citrobacter* (CRCF, LMP802) and two fungi namely *Candida albicans* (*C. albicans* LMP709U) and *Microsporum audouinii* (*M. audouinii*, LMP725D). *M. smegmatis* was cultured on Middlebrook 7 H11 agar and allowed to grow for 24 h. *M. tuberculosis* was plated on Löwenstein--Jensen medium and allowed to grow for 3--4 weeks at 37 °C. The 7 H9 broth was used to determine the minimal inhibition concentration (MIC) of the test samples on *M. smegmatis* and *M. tuberculosis*. Other microbial species were clinical isolates from Yaoundé General Hospital (Cameroon). Their identity was confirmed before use at the Laboratory of Applied Microbiology and Molecular Pharmacology (LMP) (Faculty of Science, University of Yaoundé I) by culturing on the specific media followed by biochemical test using API system as previously reported \[[@B13]\]. All the studied microorganisms were maintained on agar slant at 4 °C at the LMP. These strains were sub-cultured on a fresh appropriate agar plate 24 hours prior to any antimicrobial test. The Mueller Hinton broth (MHB) was used to determine the MIC of all samples against the tested pathogens. The MHB and Mueller Hinton Agar (MHA) were used to determine the minimal microbicidal concentration (MMC) of the active samples.

Microplate susceptibility testing against M. Smegmatis
------------------------------------------------------

All extracts were tested against *M. smegmatis* using the microplate dilution method. The MIC, MBC and bacteria preparation were performed in 96-well microplates as previously described \[[@B14],[@B15]\]. The crude extracts were dissolved in 10% dimethylsulfoxide (DMSO) in sterile 7 H9 broth to obtain a stock concentration of 10 mg/ml. Serial two-fold dilutions of each sample to be evaluated were made with 7 H9 broth to yield volumes of 100 μl/well with final concentrations ranging from 19.53--2500 μg/ml. Ciprofloxacin served as the positive drug control. One hundred microlitre of *M. smegmatis* (0.2 log-phase, yielding 1.5 × 10^6^ CFU/ml) were also added to each well containing the samples. The solvent control, DMSO at 2.5% or less in each well did not show inhibitory effects on the growth of *M. smegmatis*. Tests were done in triplicates. The cultured microplates were sealed with parafilm and incubated at 37 °C for 24 h. The MIC was detected following addition (40 μl) of 0.2 mg/ml *p*-iodonitrotetrazolium chloride (INT, Sigma-Aldrich) and incubated at 37 °C for 30 min \[[@B16],[@B17]\]. Viable bacteria reduced the yellow dye to a pink color. MIC was defined as the lowest sample concentration that prevented this change and exhibited complete inhibition of bacterial growth. The MBC was determined by adding 50 μl aliquots of the preparations (without INT), which did not show any growth after incubation during MIC assays, to 150 μl of 7 H9 broth. These preparations were incubated at 37 °C for 48 h. The MBC was regarded as the lowest concentration of extract, which did not produce a color change after addition of INT as above mentioned.

Antitubercular rapid radiometric assay using mycobacterium tuberculosis
-----------------------------------------------------------------------

The radiometric respiratory technique using the BACTEC 460 system (Becton Dickinson Diagnostic Instrument, Sparks, MD) was used for susceptibility testing against *M . tuberculosis* as described previously \[[@B17]-[@B19]\] with some modifications. Solutions of all the samples were prepared in Dimethylsulfoxide (DMSO) to obtain a stock concentration. Control experiments showed that a final concentration of DMSO at 1% in the medium had no adverse effect on the growth of *M. tuberculosis*. The primary drug INH served as drug-control. A homogenous culture (0.1 ml of *M. tuberculosis*, yielding 1 × 10^4^ to 1 × 10^5^ CFU/ml) was inoculated in the vials containing samples as well as control vials \[[@B20]\]. Three sample-free vials were used as controls (medium + 1%DMSO); two vials (V1) were inoculated in the same way as the vials containing the sample, and one (V2) was inoculated with a 1:100 dilution of the inoculum (1:100 control) to produce an initial concentration representing 1% of the bacterial population (1 × 10^2^ to 1 × 10^3^ CFU/ml). *Mycobacterium* growing in 7 H12 medium containing ^14^ C labeled substrate (palmitic acid) uses the substrate and produced ^14^CO~2~. The amount of ^14^CO~2~ detected is expressed in terms of the growth index (GI) \[[@B21]\]. Vials were incubated at 37 °C and each was assayed everyday to measure the GI. On the Bactec TB-460 system, the GI is recorded on a scale of 0--999. Growth is detected when GI ≥ 20. Then the GI value of 10 represents the growth of 1% of the bacterial population, once the inoculum control reach 999. Therefore, the MIC was considered as the lowest concentration inhibiting more than 99% of the initial bacterial population. This was taken as the lowest concentration of the sample with recorded Δ*G* \< 10. Δ*G* = *Gx* − *G*0; *Gx* being the GI of the treated medium on the day that control inoculum vial reach 999, *G*0 the GI at the first day of reading and Δ*G*, the difference between *Gx* and *G0*\[[@B22]\].

Antimicrobial assay on gram-positive, gram-negative bacteria and fungi
----------------------------------------------------------------------

The MICs of crude extracts and reference antibiotics (RA) (gentamicin for bacteria and nystatin for fungi) were determined as follows: the test sample was first of all dissolved in dimethylsulfoxide (DMSO). The solution obtained was added to MHB to give a final concentration of 2500 μg/ml for the crude extracts and 78.12 for RA. This was serially diluted two fold to obtain concentration ranges of 19.53 to 2500 μg/ml for the crude extracts and 0.31 to 78.12 μg/ml for RA. One hundred microlitre of each concentration were added to each well (96- wells microplate) containing 95 μl of NBGP and 5 μl of inoculum (standardized at 1.5 10^6^ CFU/ml by adjusting the optical density to 0.1 at 600 nm SHIMADZU UV-120-01 spectrophotometer) \[[@B23],[@B24]\]. The final concentration of DMSO in the well was less than 1% (preliminary analyses with 1% (v/v) DMSO do not affect the growth of the test organisms). The negative control well consisted of 195 μl of MHB and 5 μl of the standard inoculum \[[@B23],[@B24]\]. The plates were covered with a sterile plate sealer, then agitated to mix the contents of the wells using a plate shaker and incubated at 37 °C for 24 hours. The assay was repeated thrice. The effect of samples was detected following addition (40 μl) of 0.2 mg/ml *p*-iodonitrotetrazolium chloride and incubated at 37 °C for 30 min \[[@B25]\]. MIC and MMC were determined as above \[[@B23],[@B24]\].

Results and discussion
======================

The results of the antimicrobial activity of the studied plant extracts are summarized in Table [2](#T2){ref-type="table"} and [3](#T3){ref-type="table"}. The results of the MIC determinations (Table [2](#T2){ref-type="table"}) showed that the extracts from *A. karoo, E. lasianthum stem* and *S. africana* were able to prevent the growth of all the tested microorganisms. All other samples showed selective activities. Phytochemicals are routinely classified as antimicrobials on the basis of susceptibility tests that produce MIC in the range of 100 to 1000 µg/ml \[[@B25]\]. Activity is considered to be significant if MIC values are below 100 μg/ml for crude extract and moderate when 100 \< MIC \< 625 μg/ml \[[@B26],[@B27]\]. Therefore, the activity recorded with *A. karoo* (leaves extract on *C. albicans, M. audouinii* and stem extract on *M. audouinii* and *K. pneumoniae*), *C. dentate* (leaves extract on *C. albicans* and stem bark extract on *C. albicans* and *S. aureus*), *E. lasianthum* on *S. aureusP. obligun* bark on *E. coli* and *M. audouiniiS. africana* on *E. coli, S. aureus* and *M. audouinii* and *K. vesitoria* aerial part on *M. tuberculosis* can be considered significant. The best activity was noted with *S. africana,* with the lowest MIC value of 39.06 μg/ml recorded on three of the nine microorganisms studied. Eight plant extracts found active against *M. smegmatis* were tested against *M. tuberculosis* (Table [2](#T2){ref-type="table"}). Interestingly, they were also found to be active against *M. tuberculosis*, the best sample being the extract the aerial part of *K. vesitoria* (MIC of 39.06 μg/ml) and that from the bark of *P. obligun* (MIC of 156.25 μg/ml). However, it has been demonstrated that the sensitivity of *M. tuberculosis* is closer to that of *M. smegmatis*, a non pathogenic microorganism \[[@B15]\]. Therefore, this microorganism can be used for a preliminary study to select samples with potential activity against *M. tuberculosis*\[[@B15]\]. Hence, the results obtained herein are in accordance with such recommendation. Alternative criteria have been described by Fabry *et al.*\[[@B28]\], which consider extracts having MIC values below 8 mg/ml to have noteworthy antimicrobial activity. Under these less stringent criteria, the overall activity recorded with most of the studied extracts can be considered important. However, the tested samples were less active than the RA on all of the microbial strains, this observation been quite normal as it is expected that a crude extract (that contained a panel of both active and non active molecules) shows less activity than a purified compound. The results of the MMC determinations (Table [3](#T3){ref-type="table"}) also showed that microbicidal effect of most of the active samples could be expected. The lowest MMC value below 100 μg/ml was recorded with *S. africana*, highlighting the good antimicrobial potency of this plant.

###### 

Minimal inhibition concentration (μg/ml) of the crude extracts and reference antibiotics

  **Tested samples**                **Tested microorganisms\***                                                                  
  --------------------------------- ----------------------------- -------- -------- -------- -------- -------- -------- -------- --------
  *A. oppositifolia* leaves         2500                          1250     625      625      312.50   312.50   \>2500   \>2500   nt
  *A. oppositifolia* stem           2500                          \>2500   \>2500   312.50   312.50   312.50   312.50   \>2500   nt
  *A. karoo* leaves                 156.25                        312.50   156.25   156.25   156.25   78.12    625      1250     nt
  *A. karoo* stem                   156.25                        312.50   78.12    156.25   78.12    156.25   78.12    1250     2500
  *B. latifolia* leaves             2500                          2500     \>2500   625      1250     625      312.50   \>2500   nt
  *C. dentata* stem bark            156.25                        156.25   156.25   156.25   156.25   78.12    1250     1250     nt
  *C. dentate* leaves               1250                          625      312.50   312.50   78.12    78.12    \>2500   1250     nt
  *E. lasianthum* leaves            1250                          312.50   156.25   625      312.50   312.50   312.50   \>2500   nt
  *E. lasianthum* stem              156.25                        312.50   312.50   156.25   39.06    78.12    312.50   1250     625
  *K. vesitoria* aerial part        2500                          2500     \>2500   625      \>2500   312.50   156.25   1250     39.06
  *P. obligum* leaves               625                           312.50   312.50   156.25   625      156.25   \>2500   \>2500   nt
  *P. obligun* stem                 625                           \>2500   \>2500   312.50   156.25   312.50   312.50   \>2500   nt
  *P. obligun* bark                 78.12                         \>2500   \>2500   \>2500   156.25   156.25   78.12    156.25   156.25
  *S. burchellii* leaves            312.50                        625      156.25   625      312.50   312.50   156.25   \>2500   312.50
  *S. burchellii* bark              156.25                        312.50   156.25   156.25   156.25   156.25   156.25   \>2500   nt
  *S. hyacithoides* leaf            625                           1250     1250     312.50   \>2500   312.50   312.50   \>2500   nt
  *S. hyacithoides* Rhizoma         625                           312.50   625      \>2500   \>2500   156.25   156.25   \>2500   nt
  *S. africana* aerial part         39.06                         312.50   312.50   156.25   39.06    156.25   39.06    312.50   312.50
  *T. capensis* aerial part         625                           \>2500   312.50   625      625      312.50   312.50   \>2500   nt
  *Z. aethiopica* leaves and stem   625                           \>2500   \>2500   312.50   \>2500   312.50   312.50   \>2500   nt
  Gentamicin                        9.76                          9.76     19.53    19.53    9.76     nt       nt       nt       nt
  Nystatin                          nt                            nt       nt       nt       nt       19.53    19.53    nt       nt
  Ciprofloxacin                     nt                            nt       nt       nt       nt       nt       nt       0.3      nt
  isoniazid                         nt                            nt       nt       nt       nt       nt       nt       nt       0.13

\*The tested microorganisms are MRSA (Methicillin-resistant *Staphylococcus aureus*), βL^+^EC (β-lactamase positive *Escherichia coli*), ARKP (Ampicillin-resistant *Klebsiella pneumoniae*), CRPA (Carbenicillin-resistant *Pseudomonas aeruginosa*), CRCF (Chloramphenicol-resistant *Citrobacter*), *C. albicans* (*Candida albicans*), *M. audouinii* (*Microsporum audouinii*); (nt): not tested.

###### 

Minimal microbicdal concentration (μg/ml) of the crude extracts and reference antibiotics

  **Tested samples**                **Tested microorganisms\***                                                         
  --------------------------------- ----------------------------- -------- -------- -------- -------- -------- -------- --------
  *A. oppositifolia* leaves         \>2500                        2500     1250     1250     625      625      nd       \>2500
  *A. oppositifolia* stem           \>2500                        nd       nd       1250     625      625      1250     \>2500
  *A. karoo* leaves                 312.50                        625      312.50   1250     312.50   312.50   1250     \>2500
  *A. karoo* stem                   625                           625      312.50   312.50   156.25   312.50   312.50   \>2500
  *B. latifolia* leaves             \>2500                        \>2500   nd       1250     2500     1250     625      \>2500
  *C. dentata* stem bark            312.50                        625      312.50   312.50   312.50   312.50   \>2500   \>2500
  *C. dentate* leaves               \>2500                        2500     625      1250     156.25   156.25   nd       \>2500
  *E. lasianthum* leaves            2500                          625      312.50   1250     625      625      625      \>2500
  *E. lasianthum* stem              625                           625      625      312.50   78.12    312.50   625      \>2500
  *K. vesitoria* aerial part        \>2500                        \>2500   nd       1250     nd       625      312.50   2500
  *P. obligum* leaves               1250                          1250     1250     625      1250     312.50   nd       \>2500
  *P. obligun* stem                 1250                          nd       nd       625      312.50   625      625      2500
  *P. obligun* bark                 312.50                        nd       nd       nd       625      312.50   312.50   \>2500
  *S. burchellii* leaves            625                           1250     312.50   1250     625      625      312.50   \>2500
  *S. burchellii* bark              312.50                        625      312.50   312.50   312.50   312.50   312.50   \>2500
  *S. hyacithoides* leaf            1250                          2500     2500     1250     nd       625      625      \>2500
  *S. hyacithoides* Rhizoma         1250                          1250     1250     nd       nd       625      625      \>2500
  *S. fricana* aerial part          78.12                         625      625      312.50   78.12    312.50   78.12    2500
  *T. capensis* aerial part         2500                          nd       1250     1250     1250     1250     625      \>2500
  *Z. aethiopica* leaves and stem   2500                          nd       nd       2500     nd       1250     625      \>2500
  Gentamicin                        19.53                         19.53    39.06    39.06    19.53    nt       nt       nt
  Nystatin                          nt                            nt       nt       nt       nt       39.06    39.06    nt
  Ciprofloxacin                     nt                            nt       nt       nt       nt       nt       nt       0.3

\*The tested microorganisms are MRSA (Methicillin-resistant *Staphylococcus aureus*), βL^+^EC (β-lactamase positive *Escherichia coli*), ARKP (Ampicillin-resistant *Klebsiella pneumoniae*), CRPA (Carbenicillin-resistant *Pseudomonas aeruginosa*), CRCF (Chloramphenicol-resistant *Citrobacter*), *C. albicans* (*Candida albicans*), *M. audouinii* (*Microsporum audouinii*); (nt): not tested; (nd): not determined as the MIC was \>2500 μg/ml.

The results of the present work can be considered important with regards to the medical importance of the studied microorganisms and the fact that most of them were found to be resistant to commonly used antibiotics. *P. aeruginosa* is an important nosocomial pathogen highly resistant to clinically used antibiotics, causing a wide spectrum of infections and leading to substantial morbidity and mortality \[[@B29]\]. Drug-resistant Enterobacteriaceae, including *K. pneumoniaeE. aerogenes* and *E. coli*, have also been classified as antimicrobial-resistant organisms of concern in healthcare facilities \[[@B30]\]. The activity of some of the extracts on *M. smegmatis* also suggested that an inhibition effect of this plant on *M. tuberculosis* could be expected as the sensitivity of this microbial species was found to be closer to *M. smegmatis*, a non pathogenic agent \[[@B15]\], and this hypothesis was confirmed herein.

Conclusion
==========

The overall results of the present work provide baseline information for the possible use of South African plant extracts in the treatment of microbial infections involving resistant phenotypes.
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